Dose-escalating, Safety, Tolerability and PK Study of TAS-119 in Combination With Paclitaxel in Patients With Advanced Solid Tumors
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02134067 |
|
Recruitment Status :
Terminated
First Posted : May 8, 2014
Last Update Posted : February 21, 2020
|
Sponsor:
Taiho Oncology, Inc.
Information provided by (Responsible Party):
Taiho Oncology, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | July 2018 |
| Actual Study Completion Date : | July 2018 |